Both in Surgical Instruments
Sonoma Pharmaceuticals vs Co-Diagnostics
Over the past year SNOA returned −70.5% and CODX returned −99.9%; their daily moves had a correlation of 0.20.
SNOA −70.5% CODX −99.9%Growth of $1, one year, split-adjusted
| Metric | SNOA | CODX |
|---|---|---|
| Price | $1.11 | $0.3614 |
| Market cap | $5.3M | $3.2M |
| Today | −2.63% | −4.89% |
| 1 month | −9.8% | −68.6% |
| 6 months | −6.7% | — |
| Year to date | −69.5% | −99.8% |
| 1 year | −70.6% | — |
| Revenue growth (YoY) | +59.6% | +2.0% |
| Gross margin | 40.2% | 72.7% |
| Net margin | −5.2% | −3782.4% |
| P/E (TTM) | — | — |
| Price / sales | 0.2× | 4.4× |
| Net cash | $5.2M | $3.6M |
| Dividend yield | — | — |
| Volatility (60d) | 40.4% | 710.7% |
| Short % of float | 2.3% | 9.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).